메뉴 건너뛰기




Volumn 16, Issue 1, 2011, Pages 95-101

Effects of adding salmeterol/fluticasone propionate to tiotropium on airway dimensions in patients with chronic obstructive pulmonary disease

Author keywords

Airway luminal area; Airway wall thickness; Chronic obstructive pulmonary disease; Fluticasone propionate; Salmeterol; Tiotropium

Indexed keywords

FLUTICASONE PROPIONATE PLUS SALMETEROL; TIOTROPIUM BROMIDE;

EID: 79952262390     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01869.x     Document Type: Article
Times cited : (18)

References (36)
  • 4
    • 53749102775 scopus 로고    scopus 로고
    • A 4-year trial of tiotropium in chronic obstructive pulmonary disease
    • Tashkin DP, Celli B, Senn S et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med. 2008; 359: 1543-54.
    • (2008) N. Engl. J. Med. , vol.359 , pp. 1543-1554
    • Tashkin, D.P.1    Celli, B.2    Senn, S.3
  • 5
    • 33645304010 scopus 로고    scopus 로고
    • Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease
    • Barnes NC, Qiu YS, Pavord ID et al. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 2006; 173: 736-43.
    • (2006) Am. J. Respir. Crit. Care Med. , vol.173 , pp. 736-743
    • Barnes, N.C.1    Qiu, Y.S.2    Pavord, I.D.3
  • 8
    • 0141558800 scopus 로고    scopus 로고
    • The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD
    • DOI 10.1378/chest.124.3.834
    • Hanania NA, Darken P, Horstman D et al. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Chest 2003; 124: 834-43. (Pubitemid 37123298)
    • (2003) Chest , vol.124 , Issue.3 , pp. 834-843
    • Hanania, N.A.1    Darken, P.2    Horstman, D.3    Reisner, C.4    Lee, B.5    Davis, S.6    Shah, T.7
  • 9
    • 47249103757 scopus 로고    scopus 로고
    • Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations
    • Ferguson GT, Anzueto A, Fei R et al. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations. Respir. Med. 2008; 102: 1099-108.
    • (2008) Respir. Med. , vol.102 , pp. 1099-1108
    • Ferguson, G.T.1    Anzueto, A.2    Fei, R.3
  • 11
    • 34447498332 scopus 로고    scopus 로고
    • A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD
    • DOI 10.1016/j.pupt.2006.06.001, PII S1094553906000654
    • Cazzola M, Andò F, Santus P et al. A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-tovery severe COPD. Pulm. Pharmacol. Ther. 2007; 20: 556-61. (Pubitemid 47077647)
    • (2007) Pulmonary Pharmacology and Therapeutics , vol.20 , Issue.5 , pp. 556-561
    • Cazzola, M.1    Ando, F.2    Santus, P.3    Ruggeri, P.4    Di, M.F.5    Sanduzzi, A.6    D'Amato, M.7
  • 12
    • 0033825960 scopus 로고    scopus 로고
    • Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function
    • Nakano Y, Muro S, Sakai H et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am. J. Respir. Crit. Care Med. 2000; 162: 1102-8.
    • (2000) Am. J. Respir. Crit. Care Med. , vol.162 , pp. 1102-1108
    • Nakano, Y.1    Muro, S.2    Sakai, H.3
  • 14
  • 15
    • 0022569206 scopus 로고
    • Centrilobular emphysema: CT-pathologic correlation
    • Foster WL Jr, Pratt PC, Roggli VL et al. Centrilobular emphysema: CT-pathologic correlation. Radiology 1986; 159: 27-32. (Pubitemid 16112185)
    • (1986) Radiology , vol.159 , Issue.1 , pp. 27-32
    • Foster Jr., W.L.1    Pratt, P.C.2    Roggli, V.L.3
  • 16
    • 0022559799 scopus 로고
    • The diagnosis of emphysema. A computer tomographic-pathologic correlation
    • Bergin C, Müller N, Nichols DM et al. The diagnosis of emphysema. A computed tomographic-pathologic correlation. Am. Rev. Respir. Dis. 1986; 133: 541-6. (Pubitemid 16127234)
    • (1986) American Review of Respiratory Disease , vol.133 , Issue.4 , pp. 541-546
    • Bergin, C.1    Muller, N.2    Nichols, D.M.3
  • 18
    • 12344263724 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease: Thin-section CT measurement of airway wall thickness and lung attenuation
    • DOI 10.1148/radiol.2342040013
    • Orlandi I, Moroni C, Camiciottoli G et al. Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation. Radiology 2005; 234: 604-10. (Pubitemid 40139937)
    • (2005) Radiology , vol.234 , Issue.2 , pp. 604-610
    • Orlandi, I.1    Moroni, C.2    Camiciottoli, G.3    Bartolucci, M.4    Pistolesi, M.5    Villari, N.6    Mascalchi, M.7
  • 19
    • 0026871146 scopus 로고
    • A self-complete measure for chronic airflow limitation: The St. George's Respiratory Questionnaire
    • Jones PW, Quirk FH, Baveystock CM et al. A self-complete measure for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am. Rev. Respir. Dis. 1992; 145: 1321-7.
    • (1992) Am. Rev. Respir. Dis. , vol.145 , pp. 1321-1327
    • Jones, P.W.1    Quirk, F.H.2    Baveystock, C.M.3
  • 21
    • 36049046128 scopus 로고    scopus 로고
    • Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: A randomised controlled trial
    • DOI 10.1136/thx.2006.071068
    • Bourbeau J, Christodoulopoulos P, Maltais F et al. Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax 2007; 62: 938-43. (Pubitemid 350084490)
    • (2007) Thorax , vol.62 , Issue.11 , pp. 938-943
    • Bourbeau, J.1    Christodoulopoulos, P.2    Maltais, F.3    Yamauchi, Y.4    Olivenstein, R.5    Hamid, Q.6
  • 25
    • 0032845858 scopus 로고    scopus 로고
    • Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma
    • DOI 10.1016/S0091-6749(99)70379-9
    • Hoshino M, Takahashi M, Takai Y et al. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J. Allergy Clin. Immunol. 1999; 104: 356-63. (Pubitemid 29420433)
    • (1999) Journal of Allergy and Clinical Immunology , vol.104 , Issue.2 I , pp. 356-363
    • Hoshino, M.1    Takahashi, M.2    Takai, Y.3    Sim, J.4
  • 28
    • 15844401603 scopus 로고    scopus 로고
    • Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD
    • DOI 10.1378/chest.127.3.965
    • Hashimoto M, Tanaka H, Abe S. Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest 2005; 127: 965-72. (Pubitemid 40775530)
    • (2005) Chest , vol.127 , Issue.3 , pp. 965-972
    • Hashimoto, M.1    Tanaka, H.2    Abe, S.3
  • 29
    • 0041853629 scopus 로고    scopus 로고
    • Bronchodilator reversibility testing in chronic obstructive pulmonary disease
    • DOI 10.1136/thorax.58.8.659
    • Calverley PM, Burge PS, Spencer S et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659-64. (Pubitemid 36976273)
    • (2003) Thorax , vol.58 , Issue.8 , pp. 659-664
    • Calverley, P.M.A.1    Burge, P.S.2    Spencer, S.3    Anderson, J.A.4    Jones, P.W.5
  • 30
    • 42949152368 scopus 로고    scopus 로고
    • Bronchodilator responsiveness in patients with COPD
    • Tashkin DP, Celli B, Decramer M et al. Bronchodilator responsiveness in patients with COPD. Eur. Respir. J. 2008; 31: 42-50.
    • (2008) Eur. Respir. J. , vol.31 , pp. 42-50
    • Tashkin, D.P.1    Celli, B.2    Decramer, M.3
  • 32
    • 38349076492 scopus 로고    scopus 로고
    • Heterogeneity of bronchoconstriction does not distinguish mild asthmatic subjects from healthy controls when supine
    • Kaminsky DA, Irvin CG, Lundblad LK et al. Heterogeneity of bronchoconstriction does not distinguish mild asthmatic subjects from healthy controls when supine. J. Appl. Physiol. 2008; 104: 10-19.
    • (2008) J. Appl. Physiol. , vol.104 , pp. 10-19
    • Kaminsky, D.A.1    Irvin, C.G.2    Lundblad, L.K.3
  • 33
    • 64849108483 scopus 로고    scopus 로고
    • Relationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPD
    • Hasegawa M, Makita H, Nasuhara Y et al. Relationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPD. Thorax 2009; 64: 332-8.
    • (2009) Thorax , vol.64 , pp. 332-338
    • Hasegawa, M.1    Makita, H.2    Nasuhara, Y.3
  • 34
    • 42149166529 scopus 로고    scopus 로고
    • Superiority of 'triple' therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD
    • DOI 10.1136/thx.2007.087213
    • Singh D, Brooks J, Hagan G et al. Superiority of 'triple' therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. Thorax 2008; 63: 592-8. (Pubitemid 351969251)
    • (2008) Thorax , vol.63 , Issue.7 , pp. 592-598
    • Singh, D.1    Brooks, J.2    Hagan, G.3    Cahn, A.4    O'Connor, B.J.5
  • 35
    • 0028997564 scopus 로고
    • Normal bronchial and pulmonary arterial diameters measured by thin section CT
    • Kim SJ, Im JG, Kim IO et al. Normal bronchial and pulmonary arterial diameters measured by thin section CT. J. Comput. Assist. Tomogr. 1995; 19: 365-9.
    • (1995) J. Comput. Assist. Tomogr. , vol.19 , pp. 365-369
    • Kim, S.J.1    Im, J.G.2    Kim, I.O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.